We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Genomics Market

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global Genomics Market was valued at USD 13.2 billion in 2016 and is projected to reach USD 30.59 billion by 2025, growing at a CAGR of 9.78% from 2017 to 2025.

Genomics is sequencing based technology which relies on finding out the nucleotide bases coupling and placement of DNA or genetic material of target organism or patient. The sequences are utilized in diverse ways, either in Healthcare and Pharmaceutical sector or in Gene therapy and Research Projects of evolutionary Biology.

Sample Infographics:




Market Dynamics:
1. Market Drivers
1.1 Increasing Growth and funds for Genomics projects
1.2 Growing demand due to less sequencing costs
1.3 Growing demands and applications of genomics in Healthcare
1.4 New company launches in Genomics sector of biotech and Bioinformatics

2. Market Restraints
2.1 High equipment cost

Market Segmentation:
1. Global Genomics Market, by Technology:
1.1 Sequencing
1.2 Microarray
1.3 PCR
1.4 Nucleic Acid Extraction and Purification
1.5 Other Technologies

2. Global Genomics Market, by Products and Services:
2.1 Instruments and Systems
2.2 Consumables
2.3 Services

3. Global Genomics Market, by Application:
3.1 Diagnostics
3.1.1 Cancer Diagnostics
3.1.2 Monogenic (Mendelian) Disorders
3.1.3 Other Diagnostic Applications
3.1.3.1 Common Diseases and Complex Disorders
3.1.3.2 Movement Disorders
3.1.3.3 HIV
3.2 Drug Discovery and Development
3.3 Precision Medicine
3.4 Agriculture & Animal Research
3.5 Other Applications

4. Global Genomics Market, by Process:
4.1 Sequencing
4.2 Library Preparation
4.3 Data Analysis

5. Global Genomics Market, by End User:
5.1 Research Centers and Academic & Government Institutes
5.2 Hospitals and Clinics
5.3 Pharmaceutical & Biotechnology Companies
5.4 Other End Users

6. Global Genomics Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Illumina
2. Agilent Technologies
3. Thermo Fisher Scientific
4. Eurofins Scientific
5. Qiagen
6. GE Healthcare
7. F. Hoffmann-La Roche
8. Oxford Nanopore Technologies
9. Bio-Rad Laboratories
10. BGI
11. Eppendorf
12. Pacific Biosciences of California
13. Danaher

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.


RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Genomics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL GENOMICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL GENOMICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL GENOMICS MARKET, BY TECHNOLOGY
5.1 Overview
5.2 Sequencing
5.3 Microarray
5.4 PCR
5.5 Nucleic Acid Extraction and Purification
5.6 Other Technologies

6 GLOBAL GENOMICS MARKET, BY PRODUCTS AND SERVICES
6.1 Overview
6.2 Instruments and Systems
6.3 Consumables
6.4 Services

7 GLOBAL GENOMICS MARKET, BY APPLICATION
7.1 Overview
7.1.1 Diagnostics
7.1.2 Cancer Diagnostics
7.1.3 Monogenic (Mendelian) Disorders
7.1.4 Other Diagnostic Applications
7.1.4.1 Common Diseases and Complex Disorders
7.1.4.2 Movement Disorders
7.1.4.3 HIV
7.2 Drug Discovery and Development
7.3 Precision Medicine
7.4 Agriculture & Animal Research
7.5 Other Applications

8 GLOBAL GENOMICS MARKET, BY PROCESS
8.1 Overview
8.2 Sequencing
8.3 Library Preparation
8.4 Data Analysis

9 GLOBAL GENOMICS MARKET, BY END USER
9.1 Overview
9.2 Research Centers and Academic & Government Institutes
9.3 Hospitals and Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users

10 GLOBAL GENOMICS MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

11 GLOBAL GENOMICS MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 Illumina
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 Agilent Technologies
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Thermo Fisher Scientific
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 Eurofins Scientific
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 Qiagen
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 GE Healthcare
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 F. Hoffmann-La Roche
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Oxford Nanopore Technologies
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 Bio-Rad Laboratories
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments

12.10 BGI
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments

12.11 Eppendorf
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments

12.12 Pacific Biosciences of California
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments

12.13 Danaher
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments

13 Appendix
13.1 Related Reports

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved